comparative effectiveness

The Institute for Clinical and Economic Review is seeking public comment on its plan to evaluate the cost-effectiveness of EGFR inhibitors and immunotherapies.

This article has been updated with a comment from one of the researchers regarding which tests will be included in the study.

This article has been updated to clarify information about NIH's Genetic Testing Registry.

The Personalized Medicine Coalition is urging its members to comment on how a draft methodology report from the Patient-Centered Outcomes Research Institute can better address comparative-effectiveness research involving molecularly targeted personalized treatments.

The Patient-Centered Outcomes Research Institute has released the first draft of its methodology report, which aims to improve the design of studies comparing the impact of differe

UBC's CER capabilities could help Sanofi opportunistically apply pharmacogenomic strategies in drug development and commercialize personalized medicines.

The firms will include pharmacogenomics and personalized medicine approaches as part of an alliance to develop drugs that are more effective in real-world settings.

Pages

The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.

Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.

Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.

In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.